Healthcare conglomerate Johnson & Johnson said Wednesday it has agreed to buy the Swiss medical device maker Synthes for $21.3bn in stock and cash. Buying Synthes would be the biggest acquisition for Johnson & Johnson, giving it a leading position in

Read more